Navigation Links
ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
Date:7/29/2010

ANA598 demonstrated potent antiviral activity, including median end-of-treatment declines in viral load ranging from 2.4 to 2.9 log10 in a three day monotherapy study in treatment-naïve genotype 1 patients.  ANA598 has also demonstrated a very favorable resistance profile.

Anadys has completed two long-term chronic toxicology studies of ANA598 (26 weeks duration in rats and 39 weeks duration in monkeys).  The No Observed Adverse Effect Level, or NOAEL, is 1000 mg/kg, the highest dose tested, in both the rat and monkey.  The completed toxicology studies support the ongoing Phase II clinical study as well as future clinical studies of longer duration.

Anadys has presented in vitro data supporting the use of ANA598 in combination with interferon-alpha as well as with other anti-HCV agents currently in development that act through diverse mechanisms.  In particular, data has shown that ANA598 is synergistic in vitro with interferon-alpha as well as representative HCV protease inhibitors, polymerase inhibitors, NS5A inhibitors and cyclophilin inhibitors.  In vitro combination treatment at clinically relevant concentrations of ANA598 with interferon-alpha as well as DAAs from multiple classes results in clearance of HCV RNA from cells rather than selection of resistant isolates.  Furthermore, ANA598 retains full activity in vitro against mutations conferring resistance to protease inhibitors, nucleoside polymerase inhibitors and non-nucleoside polymerase inhibitors that act at binding sites distinct from that of ANA598, while protease and nucleoside polymerase inhibitors retain full activity in vitro against mutations conferring resistance to ANA598.

ANA598 has received Fast Track Status from the FDA for the treatment of chronic hepatitis C.

Safe Harbor Statement


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
11. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... PARK, Calif. , March 3, 2015  BioPharmX ... the development of novel drug delivery products to address ... announced that Jim Pekarsky , chief executive officer ... th Annual Roth Capital Partners Conference on Wednesday, ... Laguna Niguel in ...
(Date:3/3/2015)...  American Biosurgical, LLC ("ABI") ( www.americanbiosurgical.com ) ... engaged in the design, development and production of ... medical device companies has announced the acquisition of ... medical cable manufacturer based in North Carolina.  The ... the name MTI Medical Cables.  ...
(Date:3/3/2015)... Calif. , March 3, 2015 /PRNewswire/ ... Council today recognized world-class manufacturing companies and ... Manufacturing Leadership Awards. Logo - ... world of intensifying global competition and accelerating, ... have distinguished themselves by embracing breakthrough innovation ...
Breaking Medicine Technology:BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 3American Biosurgical Acquires MTI Corporation 22015 Manufacturing Leadership Award Winners Announced 22015 Manufacturing Leadership Award Winners Announced 32015 Manufacturing Leadership Award Winners Announced 42015 Manufacturing Leadership Award Winners Announced 52015 Manufacturing Leadership Award Winners Announced 6
... Fla., March 14, 2011 American Scientific Resources, ... "Company") announces that British-based Syner-Med (Pharmaceutical Products) Ltd. ... United Kingdom and Republic of Ireland for its ... 5,000 non-contact thermometers, comprised of both retail and ...
... Transgenomic, Inc. (OTC Bulletin Board: TBIO ... with the Dana-Farber Cancer Institute, Boston, MA, for the ... Transgenomic had licensed exclusive rights to COLD-PCR for Sanger ... the technology covered to include Ice COLD-PCR, a technique ...
Cached Medicine Technology:American Scientific Resources Announces New Distributor Syner-Med Placing Kidz-Med VeraTemp in the United Kingdom and Ireland 2American Scientific Resources Announces New Distributor Syner-Med Placing Kidz-Med VeraTemp in the United Kingdom and Ireland 3Transgenomic Expands COLD-PCR License 2Transgenomic Expands COLD-PCR License 3Transgenomic Expands COLD-PCR License 4
(Date:3/3/2015)... 03, 2015 Loma Linda University Health ... and well being, it will be offering new, healthier ... campuses. , Over the past year, a cross-section of ... creating dietary criteria, listening to vendors, sampling their products, ... organization. , Most recently, a food fair was ...
(Date:3/3/2015)... Chicago, Il. (PRWEB) March 03, 2015 ... – is set to reveal the world’s first fully ... you are breathing and controls an air purifier to ... the user informed, and in control, via phone, tablet ... air purifiers in over 50 countries worldwide, will unveil ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The human ... of the augmentation market. The wearable augmentation sector is ... of size in the upcoming years. , The ... owing to a big number of new products launches ... American region, high technological advancements as well as the ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Daylight Savings Time ... Sanjeev Kothare, MD, has tips for parents. , Parents and ... 8 at 2:00 a.m. when they set their clocks forward ... wake up that day -- one hour earlier -- you ... why parents should start thinking about “sleep hygiene” for their ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Sunday, March 1, ... No matter the time of year, every region of the ... , That’s why Amica Insurance is sharing the ... and Ready.gov to help keep you safe in the event ... Keep dry: Change wet clothing frequently to prevent loss of ...
Breaking Medicine News(10 mins):Health News:Loma Linda University Health Rejuvenates Its Vending Machines with Healthier Selections 2Health News:Smart sensor and air purifier interconnect to track and trap dust, pollen and dangerous particles in home and workplace air 2Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Amica Insurance Has Tips for National Severe Weather Preparedness Week 2
... , , WASHINGTON, ... cancer risks of cell phone radiation, especially for children, will bring ... The goal of the conference is to propose a U.S. research ... on cell phones and human health and public policy implications will ...
... , PALM CITY, Fla., Aug. 31 Connectyx ... today that the Company has received an initial purchase order ... supermarket chain headquartered in Matthews, N.C., whose stores include a ... order came through AmerisourceBergan, a comprehensive pharmaceutical services provider and ...
... linked to melanoma could be targets for treatment, researchers ... have isolated a group of genetic mutations involved in ... cancer. Their work may lead to therapies with existing ... Yardena Samuels of the National Human Genome Research Institute, ...
... , Politics and Possibilities of Health Care Reform ... 31 URAC , the ... key policy makers and insurance leaders will lead a discussion, titled "Federal ... at URAC,s 10th Annual Quality Summit and Exhibit . ...
... , DEERFIELD, Ill., Aug. 31 Chicago-based ... Corporate Achievement by the Illinois Chapter of the Huntington,s Disease Society ... disease (HD) community and making a meaningful contribution to the lives ... this past Friday at the fifth annual Celebration of Hope ...
... , FREMONT, Calif., Aug. 31 ... today announced an agreement with The Las Vegas Institute for ... post-graduate dental education, to feature premium dental lasers at LVI ... new partnership builds on HOYA ConBio,s long-standing involvement at LVI ...
Cached Medicine News:Health News:Cell Phones and Health: Is There a Brain Cancer Connection? 2Health News:Connectyx Launches MedFlash Electronic Personal Health Record with Harris Teeter Supermarket Chain 2Health News:Genetic Clues May Lead to New Skin Cancer Therapies 2Health News:Policy Makers Discuss Health Care Reform at URAC Quality Summit 2Health News:Policy Makers Discuss Health Care Reform at URAC Quality Summit 3Health News:Lundbeck Inc. Recognized With Award of Excellence in Corporate Achievement for Its Commitment to Huntington's Disease Community 2Health News:Lundbeck Inc. Recognized With Award of Excellence in Corporate Achievement for Its Commitment to Huntington's Disease Community 3Health News:HOYA ConBio Announces Educational Alliance with LVI Global Australia 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: